Insider Trading April 3, 2026

Photronics Director Disposes of $423K in Shares Amid Positive Quarterly Results

Mitchell G. Tyson offloads 10,000 Photronics (PLAB) shares as company posts Q1 fiscal 2026 beat and plans equipment expansion in Korea

By Sofia Navarro PLAB
Photronics Director Disposes of $423K in Shares Amid Positive Quarterly Results
PLAB

Photronics INC director Mitchell G. Tyson sold 10,000 shares on April 1, 2026, generating roughly $423,100 in proceeds. The sale occurred across several trades at prices between $42.28 and $42.45 per share. Tyson retains a direct stake of 33,199 shares. The insider move comes while PLAB shares trade at $40.85, having risen 125% over the past year. Photronics reported fiscal Q1 2026 earnings and revenue ahead of expectations and announced plans to add a mask writer at its Korea facility in fiscal Q2 2026. Analyst Craig-Hallum raised its price target to $48 from $42 while keeping a Buy rating.

Key Points

  • Photronics director Mitchell G. Tyson sold 10,000 shares on April 1, 2026, generating roughly $423,100; sale prices ranged from $42.28 to $42.45 per share and he now directly owns 33,199 shares.
  • Photronics reported fiscal Q1 2026 EPS of $0.61, a 15.82% beat versus the $0.5267 estimate, and revenue of $225.07 million, beating the $220.83 million estimate by 1.92%.
  • The company plans to install a mask writer at its Korea facility in fiscal Q2 2026 to expand AMOLED photomask production; Craig-Hallum raised its price target from $42 to $48 and kept a Buy rating.

Mitchell G. Tyson, serving on the board of Photronics INC (NASDAQ:PLAB), completed the sale of 10,000 shares of the company's common stock on April 1, 2026, receiving approximately $423,100 in aggregate proceeds.

The disposal was executed over multiple transactions, with executed prices ranging from $42.28 to $42.45 per share. After these transactions, Tyson continues to directly hold 33,199 Photronics shares.


Market context for the sale is notable. At the time the sale was reported, Photronics shares were trading at $40.85, representing a 125% increase over the prior 12 months. An InvestingPro analysis cited in company data characterizes the stock as appearing overvalued relative to its Fair Value. Photronics trades with a price-to-earnings ratio of 17.51 and a market capitalization of $2.41 billion.

Tyson's sale coincides with a set of operational and financial updates from Photronics. The company reported fiscal Q1 2026 results that exceeded analyst expectations. Earnings per share for the quarter were $0.61, beating the forecast of $0.5267 by 15.82%. Revenue for the period came in at $225.07 million versus an estimated $220.83 million, an outperformance of 1.92%.

Alongside the quarterly results, Photronics announced plans to install a new mask writer at its Korea facility during fiscal Q2 2026. The company said the equipment will be used to expand production of AMOLED photomasks and is intended to improve stability, accuracy, and resolution in that product line.

Following these developments, analyst firm Craig-Hallum adjusted its valuation outlook, increasing its price target for Photronics from $42 to $48 while maintaining a Buy rating. The firm cited Photronics' positioning as semiconductor manufacturers continue to outsource photomask production as a factor in the reassessment.

The combination of an insider sale, a significant share-price gain over the past year, above-consensus quarterly results, and planned capital investments in photomask equipment paints a mixed picture for investors assessing both near-term performance and longer-term strategic positioning.

Risks

  • The insider sale occurred while Photronics shares trade at $40.85 and are described by InvestingPro analysis as appearing overvalued relative to Fair Value - valuation risk for equity investors.
  • Planned capital deployment on a Korea facility mask writer carries execution and timing uncertainty tied to fiscal Q2 2026 implementation, which could affect production improvements.
  • Market reliance on semiconductor outsourcing dynamics underpins analyst optimism; shifts in that trend could impact demand for Photronics' photomasks and related revenues.

More from Insider Trading

CoreWeave Executive Executes $111.6 Million Stock Sale Under 10b5-1 Plan Apr 3, 2026 Natera Legal Chief Sells $1.7M in Stock as Firm Advances Genomics Pipeline Apr 3, 2026 Natera Executive Sells $606,899 in Stock Under Pre-Arranged Plan Apr 3, 2026 CoreWeave CEO Completes $34.9 Million Share Sales; Company Reports Technical and Financing Milestones Apr 3, 2026 Amalgamated Financial EVP Sells $195K in Stock; Q4 2025 Revenue Tops Estimates Apr 3, 2026